End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.56 EGP | -5.19% | 0.00% | -18.47% |
Mar. 03 | Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 05 | Ibnsina Pharma(CASE:ISPH) added to EGX 30 Index | CI |
Sales 2024 * | 37.57B 798M | Sales 2025 * | 44.09B 936M | Capitalization | 2.72B 57.78M |
---|---|---|---|---|---|
Net income 2024 * | 316M 6.71M | Net income 2025 * | 417M 8.85M | EV / Sales 2024 * | 0.17 x |
Net Debt 2024 * | 3.72B 78.98M | Net Debt 2025 * | 3.56B 75.62M | EV / Sales 2025 * | 0.14 x |
P/E ratio 2024 * |
9
x | P/E ratio 2025 * |
7.01
x | Employees | 5,500 |
Yield 2024 * |
1.44% | Yield 2025 * |
2.86% | Free-Float | 60.26% |
1 day | -2.53% | ||
1 week | +5.47% | ||
Current month | -28.95% | ||
1 month | -26.03% | ||
3 months | -14.01% | ||
6 months | +35.68% | ||
Current year | -14.01% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 00-12-17 | |
Chief Executive Officer | - | 00-12-17 | |
Momen Gomaa
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | - | |
Chief Executive Officer | - | 00-12-17 | |
Chief Executive Officer | - | 00-12-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 2.56 | -5.19% | 9 369 508 |
24-03-27 | 2.7 | -2.53% | 10,467,700 |
24-03-26 | 2.77 | -2.12% | 16,162,580 |
24-03-25 | 2.83 | +5.20% | 14,811,050 |
24-03-24 | 2.69 | +1.13% | 14,637,520 |
End-of-day quote Egyptian Exchange, March 26, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.01% | 57.61M | |
-19.49% | 18.13B | |
-29.16% | 11.09B | |
-2.90% | 6.79B | |
-0.60% | 5.57B | |
+10.80% | 5.26B | |
+34.14% | 3.93B | |
-9.43% | 3.75B | |
+4.30% | 3.55B | |
-15.38% | 3.32B |